Alendronate and Raloxifene Therapy in the Early Period after Hip Fracture

Objective: The purpose of the present study was to clarify the efficacy of alendronate and raloxifene for preventing bone loss in patients with hip fracture by monitoring bone mineral densities (BMDs) and biochemical markers during the 9-month period after fracture. Patients and Methods: Eighty-two...

Descripción completa

Detalles Bibliográficos
Autores principales: Ohishi, Tsuyoshi, Ichikawa, Tetsuya, Ito, Takanori, Koyama, Hiroshi, Miyagi, Michihito, Hoshino, Hironobu, Takahashi, Masaaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Association of Rural Medicine 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309344/
https://www.ncbi.nlm.nih.gov/pubmed/25650026
http://dx.doi.org/10.2185/jrm.6.16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309344/
https://www.ncbi.nlm.nih.gov/pubmed/25650026
http://dx.doi.org/10.2185/jrm.6.16

Ejemplares similares